Latest Breaking News On - Regulatory officer - Page 8 : comparemela.com

MTN appoints Mike Silber as regulatory officer

MTN Group has appointed Mike Silber as its Group Executive Regulatory Officer, effective April 1, 2024.

South africaSouth africanLele modiseMike silberCentre at witsResearch network of south africaInternet corporation for assigned namesMtn groupGroup executive regulatoryUniversity of the witwatersrandGroup executive regulatory officerLiquid telecomGroup chief regulatory officerChief legalRegulatory officerInternet corporation

C3iHub, IIT Kanpur launches startup cohorts to drive cybersecurity innovation and foster entrepreneurship

C3iHub, IIT Kanpur launches startup cohorts to drive cybersecurity innovation and foster entrepreneurship
webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.

Uttar pradeshNew delhiBharat panchalAjay kumarAbhay karandikarEkta kapoorSandeep shuklaGulshan raiManindra agrawalNavin kumar singhStartup incubation programmeNational cyber security coordinatorDrone technologyTechnology innovation hubsNational technology innovation hubIndian institute of technology kanpur

MTN : appoints Mike Silber, as Group Executive Regulatory -March 28, 2024 at 06:34 am EDT

MTN Group announces the appointment of Mike Silber, as Group Executive Regulatory, effective 1 April 2024. He joins MTN Group from Liquid Telecom, where he held the role of Group Chief.

South africaSouth africanMike silberLele modiseResearch network of south africaGroup executive regulatoryUniversity of the witwatersrandCentre at witsInternet corporation for assigned namesLiquid telecomGroup chief regulatory officerGroup chief legalRegulatory officerInternet corporationAssigned namesTertiary education

Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025

Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025           Lead program TG4050 to deliver data in 2024.         Advancements in other clinical pr.

Carol stuckleyLucie larguierPedro romeroJames wentworthMaud brandely talbotChristelle schwoererJohnc bellAlessandro rivaChristophe ancelJohn felittiCanadian oncolytic virus consortiumUniversity of lausanneMerck coTransgene management committeeEuronext parisEuropean journal

Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025 -March 27, 2024 at 12:45 pm EDT

2023 Full-year results and business update Lead program TG4050 to deliver data in 2024. Advancements in other clinical programs and Research and Innovation activity to.

John felittiFrazer hall sylvie berrebiLucie larguierChristelle schwoererMaud brandely talbotChristophe ancelTransgene euronextJohnc bellCarol stuckleyPedro romeroJames wentworthAlessandro rivaCanadian oncolytic virus consortiumMerck coTransgene management committeeUniversity of lausanne